The drug major’s consolidated net profit increased 36.26% to Rs 1,307 crore on 12.49% rise in revenues to Rs 7,083 crore in Q4 FY24 over Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The drug major’s consolidated net profit increased 36.26% to Rs 1,307 crore on 12.49% rise in revenues to Rs 7,083 crore in Q4 FY24 over Q4 FY23.
| Subscribe To Our Free Newsletter |
